Skip to main content
Figure 1 | Virology Journal

Figure 1

From: First-generation protease inhibitor-triple therapy: SVR 24, safety, and predictors of response in a large single center cohort

Figure 1

Overall treatment outcome in the TVR and BOC patient subgroups (ITT). *two of those patients reached SVR 12, but did not show up to SVR 24; **four patients reached SVR 24 despite premature discontinuation and therefore were added to the SVR 24-column; #one patient lost to follow-up; ##one patient reached SVR 24 despite premature discontinuation and therefore was added to the SVR 24-column. Abbreviations: BOC: boceprevir, TVR: telaprevir; SVR: sustained virological response.

Back to article page

Virology Journal

ISSN: 1743-422X